TransMedics raised a $20 million funding round for its organ preservation and transportation device, according to a regulatory filing.
Eleven unnamed investors participated in the round for Andover, Mass.-based TransMedics, according to the filing.
The TransMedics organ care system is designed to perfuse the heart or other organs with warm, oxygenated blood, continuously monitoring their status until transplantation.
The company claims its platform is the only medical device capable of maintaining donor organs in near physiologic and functioning state outside of the human body, from the time the organ is removed from a donor until it’s ready to be transplanted.
In November 2012, TransMedics notched the 1st “breathing lung” transplant using the OCS device.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!